about
A case of mixed connective tissue disease complicated with thrombotic thrombocytopenic purpura.Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants.The ventilatory responsiveness to CO(2) below eupnoea as a determinant of ventilatory stability in sleep.Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma.Mandibular Advancement Device as a Comparable Treatment to Nasal Continuous Positive Airway Pressure for Positional Obstructive Sleep Apnea.A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis.Mechanisms and prevention of sudden death in multiple system atrophy.Superiority of respiratory failure risk index in prediction of postoperative pulmonary complications after digestive surgery in Japanese patients.Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.Natural course and potential prognostic factors for sleep-disordered breathing in multiple system atrophy.Esophageal Involvement in Multiple System Atrophy.Tremulous arytenoid movements predict severity of glottic stenosis in multiple system atrophy.Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep.Discontinuation of continuous positive airway pressure treatment in multiple system atrophy.Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome.Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea.Facial axis angle as a risk factor for obstructive sleep apnea.Ventilatory responsiveness to CO2 above & below eupnea: relative importance of peripheral chemoreception.Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.Progression of obstructive sleep apnoea syndrome in Japanese patients.Hypoxic ventilatory response during light and dark periods and the involvement of histamine H1 receptor in mice.Selection of response criteria affects the success rate of oral appliance treatment for obstructive sleep apnea.Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome.[Pulmonary thromboembolism during the Niigata Chuetsu earthquake in 2004].Effects of fasting on hypoxic ventilatory responses and the contribution of histamine H1 receptors in mice.Breathing Irregularity Is Independently Associated With the Severity of Obstructive Sleep Apnea in Patients With Multiple System AtrophyDirect evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosisSignificance and usefulness of heart rate variability in patients with multiple system atrophyMaintaining glottic opening in multiple system atrophy: efficacy of serotonergic therapy[Effects of anticoagulant therapy for rapidly progressive interstitial pneumonias]Factors influencing the cognitive function in patients with multiple system atrophy[Considering the perioperative non-invasive positive pressure ventilation from the standpoint of a respiratory physician]Obstructive sleep apnea phenotypes in men based on characteristics of respiratory events during polysomnography
P50
Q33369798-AE54C20D-F641-4FF2-B13E-E82A2F779278Q34463868-19802A1D-F045-4FA5-9D71-A2A056252ED6Q35850899-117E7BA7-68C7-4785-800A-2787F16624B2Q36952452-C5C9D983-C8D6-426E-B5CF-B8179A14D7F9Q37117687-12930E54-B247-4DCA-9A6D-C2C38D2AD06EQ38685636-E6213A6F-4B08-4522-BD55-C1F62B960CCCQ38814597-108CF7E7-1C5F-4E82-8312-64BCFAB4C0EBQ39009896-D8E42C5B-5EBC-48F7-A7EC-5C4C5682BE63Q39514845-CFC58777-EFE4-417A-BA6B-015ED1852A79Q40207038-64CF2473-CFC6-4639-89F1-9EA9D0179B72Q41554024-BC14C8A1-C28C-4C1C-BE25-28E6B992094CQ43121306-2F5FCBB2-F203-4535-BC8B-B9BC95DA53D9Q43980951-A6F8F7BC-928E-4B0B-83AD-F7817CCF0134Q44236467-3BEE7C04-F757-4B44-99EF-C29EC444AF51Q44931989-521F54D0-F4C9-4BA1-9F25-193BBC1B3E05Q46781883-5850DA49-FEAE-4841-933E-53CDF3E88A4BQ47729585-8F71C528-C436-4498-AC24-16E52C9F655DQ47878940-F42AE2ED-F8A0-439A-A5D8-5DFEF7B40F8AQ47915875-D6BCF70E-42AE-4A29-A8B4-6EF8F52BF24AQ47916501-E80C842A-4831-430D-BDAC-B2D48957776EQ48107932-03D73CE3-81C9-4D8E-8E0D-F517CCFD3B65Q48124254-1FA17BFA-1280-4BBC-8DEA-F1146435CDE1Q48630164-D97C361A-941D-4CF6-92B2-2F0AD2DD63E2Q50087196-7657769C-58EF-4BE5-8536-5D8DC54D2E94Q51383581-59AB3ADC-2997-4F1F-88AC-50DDBB25D3F3Q57819491-5B39F44B-C17D-4BE9-9E8B-C61113B2CCE2Q82658295-1760A793-3020-4148-A7E1-AC9D95705094Q83364286-C828D10E-0EA4-4611-A6E8-CF444D722E52Q83936514-698F383A-91FF-471B-824B-810C3E408625Q84514851-C80835F3-9FAB-4153-BB52-6962BEF92311Q85162921-9512B030-BE63-444D-9D33-D69C539DFF7EQ86436049-80BFF08D-A560-49A4-A4C0-D694BE6BEE9FQ91261698-3D2F8ADF-8201-4FB5-BD07-9BBC68642B04
P50
description
researcher ORCID ID = 0000-0001-5405-9073
@en
wetenschapper
@nl
name
Hideaki Nakayama
@ast
Hideaki Nakayama
@en
Hideaki Nakayama
@es
Hideaki Nakayama
@nl
type
label
Hideaki Nakayama
@ast
Hideaki Nakayama
@en
Hideaki Nakayama
@es
Hideaki Nakayama
@nl
prefLabel
Hideaki Nakayama
@ast
Hideaki Nakayama
@en
Hideaki Nakayama
@es
Hideaki Nakayama
@nl
P106
P31
P496
0000-0001-5405-9073